Shopping Cart
Remove All
Your shopping cart is currently empty
RC-106, a proteasome inhibitor (IC50: 35 μM) and Sigma receptor modulator, exhibits anticancer activity and antiproliferative effects against cancer cells, including glioblastoma (GB) and multiple myeloma (MM) [1].

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | RC-106, a proteasome inhibitor (IC50: 35 μM) and Sigma receptor modulator, exhibits anticancer activity and antiproliferative effects against cancer cells, including glioblastoma (GB) and multiple myeloma (MM) [1]. |
| In vitro | RC-106, when administered at a concentration of 60 μM for 24 hours, was found to inhibit the viability of cancer cells [1]. In a cell viability assay [1] using U87-MG cells, RC-106 demonstrated moderate activity. Specifically, at concentrations of 40 and 60 μM over an incubation period of 24 hours, it notably reduced cell viability to 34% at the higher concentration. |
| Molecular Weight | 355.52 |
| Formula | C26H29N |
| Cas No. | 1346216-50-9 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.